Back
HFA Premium Access

Effect of dapagliflozin on individual components of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

Session: Chronic heart failure - pharmacotherapy 2
Topic: Pharmacotherapy
Speaker: Doctor A. Peikert (Graz, AT)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Alexander Peikert

Medical University of Graz, Graz (Austria)
0 follower

7 more presentations in this session

Survey and interview-based study on readiness of heart failure polypill implementation

Speaker: Doctor R. Bin Raja Shariff (Selangor, MY)

Access
Abstract
Slides
Like
Thumbnail

Atrioventricular conduction disorders associated to betablocker treatment in patients with heart failure

Speaker: Doctor D. Marcu (Iasi, RO)

Access
Abstract
Slides
Like
Thumbnail

The efficacy of combination therapy of corticosteroids and methotrexate for cardiac sarcoidosis, prolonged analysis

Speaker: Doctor Y. Nishihata (Tokyo, JP)

Access
Abstract
Slides
Like
Thumbnail

Transthyretin-directed antisense oligonucleotide therapy effects on ATTRv myocardiopathy

Speaker: Doctor A. Garcia (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Telmisartan versus Enalapril in heart failure with reduced ejection fraction patients with moderately impaired kidney functions; randomized controlled trial. (TRIUMF trial)

Speaker: Doctor S. Abouel Naga (Cairo, EG)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Chronic heart failure - pharmacotherapy 2

Speakers: Doctor A. Peikert, Doctor R. Bin Raja Shariff, Doctor D. Marcu, Doctor Y. Nishihata, Doctor A. Garcia...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources